Investigations Regarding B-cell Subsets in Humans
NCT00926692 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 249
Last updated 2015-08-26
Summary
The aim of this research is to define the human equivalent of mouse B1 cells.
Conditions
- Healthy
Interventions
- OTHER
-
Blood draw
Subject will have blood draw.
Sponsors & Collaborators
-
Northwell Health
lead OTHER
Principal Investigators
-
Daniel Griffin, M.D. · Feinstein Institute for Medical Research
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2009-04-30
- Primary Completion
- 2014-07-31
- Completion
- 2014-07-31
Countries
- United States
Study Locations
More Related Trials
-
PBMC Collection for Production of UCAR T Cells
NCT04963959 ·Status: UNKNOWN ·Phase: NA
-
Development of a Cell Culture Process for the Production of Human T-lymphocyte Precursors
NCT05118113 ·Status: UNKNOWN ·Phase: NA
-
Distribution of Immune Cells Subsets in Healthy Females
NCT05609799 ·Status: COMPLETED ·Phase: NA
-
Collection of Peripheral Blood Mononuclear Cells (PBMCs) From Healthy People for the Expansion of T Cells for Adoptive Cell Therapy
NCT02821806 ·Status: RECRUITING
-
Prospective Study of White Blood Cells
NCT04838171 ·Status: RECRUITING
-
Collection and Generation of Antigen-specific T-lymphocyte Cell Lines From Primary, Third-party, Related, and Unrelated Donors
NCT03114566 ·Status: TERMINATED
-
A Therapeutic Protocol in Previous Failed ART Patients With High Total NK Cells
NCT03792997 ·Status: COMPLETED ·Phase: PHASE2
-
Transcriptomics Signature of Anti Vaccinia Memory B Cells
NCT02556489 ·Status: UNKNOWN
-
Safety, Tolerability and Efficacy of GcMAF in Patients With Chronic Inflammatory Diseases
NCT06877364 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Biospecimen Collection Study of Leukapheresis-Derived Circulating Tumor Cells, Immune Cells, and Progenitor Cells.
NCT00571389 ·Status: RECRUITING
-
Long-term Follow-Up Study Following Treatment With Fate Therapeutics' Engineered Cellular Immunotherapy
NCT04093622 ·Status: TERMINATED
-
Assessment of Blood and Follicular Fluid Immune Cell Constitution in Patients Undergoing in Vitro Fertilization
NCT01083745 ·Status: UNKNOWN
-
Blockade of PD-1 in Conjunction With the Dendritic Cell/AML Vaccine Following Chemotherapy Induced Remission
NCT01096602 ·Status: COMPLETED ·Phase: PHASE2
-
Study of the Kinetics of Antibodies Against COVID-19 (SARS-CoV-2) and of Cellular Subpopulations of the Immune System
NCT04743388 ·Status: UNKNOWN
-
Age-matched Reference Values for Circulating Natural Killer T-like Cells
NCT06450743 ·Status: COMPLETED ·Phase: NA
-
Anti-Pseudomonas Immune Status and Dendritic Cell Preparation in Normal Individuals
NCT00320164 ·Status: COMPLETED
-
Collection of Data and Samples From Healthy Donors for Use in Translational Research
NCT00090662 ·Status: RECRUITING
-
Evaluation of Immune Signaling Networks in Healthy Human Volunteers
NCT01882582 ·Status: COMPLETED
-
A Phase 1 Study of MEDI0562 in Adult Subjects With Selected Advanced Solid Tumors
NCT02318394 ·Status: COMPLETED ·Phase: PHASE1
-
DLL3-Directed Chimeric Antigen Receptor T-cells in Subjects With Extensive Stage Small Cell Lung Cancer
NCT05680922 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
The Impact of CAR-T Cell Therapy on Fertility; A Patient Survey
NCT07173322 ·Status: RECRUITING
-
Induction of Cytokines in Human Monocytes by SARS-CoV in Adults and Children
NCT00173563 ·Status: UNKNOWN
-
Immune Cell Response to Stimuli
NCT00397280 ·Status: RECRUITING
-
Natural Killer Cells Functions, Tumoral Escape to Immune System and Regulation of Natural Cytotoxixity Receptors in Haematological Malignancies
NCT01915992 ·Status: UNKNOWN ·Phase: NA
-
Study Evaluating SARS-CoV-2 (COVID-19) Humoral Response After BNT162b2 Vaccine in Immunocompromised Adults Compared to Healthy Adults
NCT04952766 ·Status: COMPLETED ·Phase: PHASE4